Therefore, apart from its role in iron depletion, deferasirox could be used to maintain hepcidin expression at normal levels and to regulate iron homoeostasis in HCC, while additionally exerting tumor-suppressive effects [213]. This evidence concerns the gene HAMP and hepatocellular carcinoma.